| Name | AHR antagonist 4 |
|---|
| Description | AHR antagonist 4 is a 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamide compound and a potent aryl hydrocarbon receptor (AHR) antagonist extracted from patent WO2018146010A1, example 293, has an IC50 of 82.2 nM. AHR antagonist 4 has anti-cancer effects[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 82.2 nM (Aryl hydrocarbon receptor (AHR))[1] |
| References |
| Molecular Formula | C20H14F6N4O4 |
|---|---|
| Molecular Weight | 488.34 |